DC Prime BV - Company Review
SummaryDC Prime BV - Company Review
Summary
DC Prime BV (DC Prime) is a clinical-stage cancer immunotherapy company that develops therapeutic vaccines for cancer treatments. The company provides DCOne, a platform technology that allows the generation of off-the-shelf dendritic cell based vaccines. Its DCOne cells express a range of tumor antigens that are targets in cancer types. DC Prime’s technology platform includes DC based vaccines with allogeneic stimulation of the immune system. The company develops DCP-001 for the second line treatment of acute myeloid leukemia and DCP 002 as an off-the-shelf therapeutic vaccine for curing human cancer. It partners with academic institutions and biotechnology companies. DC Prime is headquartered in Leiden, the Netherlands.
This comprehensive company report of DC Prime BV provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.